TANVEX BIOPHARMA USA, INC.

Tanvex BioPharma appoints Stephen Lam as CEO, effective September 5, 2024. Lam will oversee integration with Bora Pharmaceuticals, driving strategic initiatives and managing global CDMO operations. With over 35 years of industry experience, Lam aims to expand Tanvex's global presence and accelerate growth.